MOR Annual Cash & Cash Equivalents
$175.21 M
-$256.28 M-59.39%
31 December 2023
Summary:
As of January 21, 2025, MOR annual cash & cash equivalents is $175.21 million, with the most recent change of -$256.28 million (-59.39%) on December 31, 2023. During the last 3 years, it has risen by +$40.16 million (+29.74%).MOR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOR Quarterly Cash And Cash Equivalents
$175.21 M
0.00%
31 December 2023
Summary:
As of January 21, 2025, MOR quarterly cash and cash equivalents is $175.21 millionOver the past year, it has dropped by -$256.28 million (-59.39%).MOR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOR Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.4% | -59.4% |
| 3 y3 years | +29.7% | +29.7% |
| 5 y5 years | +236.9% | +29.7% |
MOR Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -59.4% | -74.4% |
MorphoSys AG Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $175.21 M(-59.4%) | $175.21 M(-12.5%) |
| June 2023 | - | $200.32 M(-37.0%) |
| Mar 2023 | - | $318.13 M(-26.3%) |
| Dec 2022 | $431.48 M(+209.2%) | $431.48 M(+247.0%) |
| June 2022 | - | $124.36 M(+2.3%) |
| Mar 2022 | - | $121.52 M(-12.9%) |
| Dec 2021 | $139.54 M(+3.3%) | $139.54 M(-51.8%) |
| Sept 2021 | - | $289.71 M(+125.5%) |
| Mar 2021 | - | $128.47 M(-4.9%) |
| Dec 2020 | $135.04 M(+172.1%) | $135.04 M(+78.8%) |
| Sept 2020 | - | $75.51 M(+101.0%) |
| June 2020 | - | $37.57 M(-94.5%) |
| Mar 2020 | - | $684.73 M(+1279.4%) |
| Dec 2019 | $49.64 M(-4.5%) | $49.64 M(-22.5%) |
| Sept 2019 | - | $64.05 M(+3.0%) |
| June 2019 | - | $62.20 M(+14.2%) |
| Mar 2019 | - | $54.49 M(+4.8%) |
| Dec 2018 | $52.00 M(-42.6%) | $52.00 M(-63.0%) |
| Sept 2018 | - | $140.57 M(+118.9%) |
| June 2018 | - | $64.21 M(-9.3%) |
| Mar 2018 | - | $70.79 M(-21.8%) |
| Dec 2017 | $90.56 M(+13.9%) | $90.56 M(-13.4%) |
| Sept 2017 | - | $104.58 M(+47.5%) |
| June 2017 | - | $70.92 M(-43.0%) |
| Mar 2017 | - | $124.50 M(+56.7%) |
| Dec 2016 | $79.48 M(-20.6%) | $79.48 M(+135.6%) |
| Sept 2016 | - | $33.74 M(-55.1%) |
| June 2016 | - | $75.18 M(-49.7%) |
| Mar 2016 | - | $149.40 M(+49.2%) |
| Dec 2015 | $100.10 M | $100.10 M(+234.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $29.96 M(-52.0%) |
| June 2015 | - | $62.44 M(+71.2%) |
| Mar 2015 | - | $36.47 M(-8.6%) |
| Dec 2014 | $39.90 M(-60.3%) | $39.90 M(-57.5%) |
| Sept 2014 | - | $93.91 M(+33.3%) |
| June 2014 | - | $70.46 M(+8.4%) |
| Mar 2014 | - | $64.98 M(-35.4%) |
| Dec 2013 | $100.58 M(+82.5%) | $100.58 M(-29.0%) |
| Sept 2013 | - | $141.58 M(+123.1%) |
| June 2013 | - | $63.45 M(+24.3%) |
| Mar 2013 | - | $51.04 M(-7.4%) |
| Dec 2012 | $55.11 M(-23.4%) | $55.11 M(-12.7%) |
| Sept 2012 | - | $63.12 M(+16.0%) |
| June 2012 | - | $54.40 M(+6.8%) |
| Mar 2012 | - | $50.96 M(-29.2%) |
| Dec 2011 | $71.99 M(+22.7%) | $71.99 M(-17.8%) |
| Sept 2011 | - | $87.59 M(+2.3%) |
| June 2011 | - | $85.65 M(+20.0%) |
| Mar 2011 | - | $71.38 M(+21.6%) |
| Dec 2010 | $58.68 M(-0.5%) | $58.68 M(+4.5%) |
| Sept 2010 | - | $56.17 M(+5.7%) |
| June 2010 | - | $53.14 M(-13.2%) |
| Mar 2010 | - | $61.25 M(+3.8%) |
| Dec 2009 | $59.00 M(+5.2%) | $59.00 M |
| Dec 2008 | $56.05 M(-20.7%) | - |
| Dec 2007 | $70.66 M(+1322.4%) | - |
| Dec 2006 | $4.97 M(+4.4%) | - |
| Dec 2005 | $4.76 M(-72.0%) | - |
| Dec 2004 | $17.00 M(+103.0%) | - |
| Dec 2003 | $8.37 M(+847.9%) | - |
| Dec 2002 | $883.30 K | - |
FAQ
- What is MorphoSys AG annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MorphoSys AG?
- What is MorphoSys AG annual cash & cash equivalents year-on-year change?
- What is MorphoSys AG quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for MorphoSys AG?
- What is MorphoSys AG quarterly cash and cash equivalents year-on-year change?
What is MorphoSys AG annual cash & cash equivalents?
The current annual cash & cash equivalents of MOR is $175.21 M
What is the all time high annual cash & cash equivalents for MorphoSys AG?
MorphoSys AG all-time high annual cash & cash equivalents is $431.48 M
What is MorphoSys AG annual cash & cash equivalents year-on-year change?
Over the past year, MOR annual cash & cash equivalents has changed by -$256.28 M (-59.39%)
What is MorphoSys AG quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MOR is $175.21 M
What is the all time high quarterly cash and cash equivalents for MorphoSys AG?
MorphoSys AG all-time high quarterly cash and cash equivalents is $684.73 M
What is MorphoSys AG quarterly cash and cash equivalents year-on-year change?
Over the past year, MOR quarterly cash and cash equivalents has changed by -$256.28 M (-59.39%)